Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $9.19, but opened at $8.67. Bavarian Nordic shares last traded at $8.67, with a volume of 228 shares trading hands.
Bavarian Nordic Trading Down 4.4%
The firm has a market cap of $2.09 billion, a price-to-earnings ratio of 11.55 and a beta of 1.19. The company has a fifty day moving average price of $9.81 and a 200-day moving average price of $9.92.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last posted its earnings results on Wednesday, May 13th. The company reported $0.01 EPS for the quarter. The firm had revenue of $165.70 million for the quarter. Bavarian Nordic had a return on equity of 9.32% and a net margin of 19.74%.
About Bavarian Nordic
Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.
The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.
Featured Stories
- Five stocks we like better than Bavarian Nordic
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
